Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Month: January 2025

1 / 1

Cracking the Patent Code: Natco’s Winning Formula

Natco Pharma, a leader in APIs and niche generics, faces growth challenges post-Revlimid exclusivity in FY26, with semaglutide offering long-term ...
Natco-Pharma.jpg

TARIL: The Pickaxe and Shovel Play in India’s Energy Transformation

TARIL is one of the leading transformer manufacturers in India, and with the country’s growing power demand, the company is well-positioned to play a crucial ...
1E1FE833-3C0C-43D8-929E-1C9FFB193201.jpeg

In Earnings We Trust: 2024 Focused Portfolio Review

For the calendar year 2024, the Focused portfolio is up 29.4%, compared to the Nifty 50’s 8.7% and the Nifty 500’s 14.8%. We started 2024 on a ...
2534337C-CC68-4314-A185-69C8EDB53D9C.jpeg